Forgot Your Password? Register Submit
Home About Us Live Programs Online Programs User Records Claim Credits Resource Downloads Help & FAQ Contact Us
Topics of Interest
Performance Improvement CME

Performance Improvement Continuing Medical Education (PI CME)

Performance Improvement Continuing Medical Education (PI CME) was introduced by the American Medical Association (AMA) in 2005. It is a process designed as a nationally standardized CME format to help healthcare professionals evaluate their current practice and improve their clinical processes and patient outcomes.

In this Performance Improvement CME activity, you will evaluate the performance in your own practice, develop and implement a plan for improving performance, and then re-evaluate your practice's performance on the selected quality measures. The program is a 3 stage process:

Stage A: Learning from Current Practice Performance Assessment (up to 5 hours of credit)

Stage B: Learning From the Application of Performance Improvement to Patient Care (up to 5 hours of credit)

Stage C: Learning From Evaluation of the Performance Improvement Effort (up to 5 hours of credit)

Bonus Credit: Physicians completing, in sequence, all three Stages (A through C) of a structured PI activity may receive an additional five (5) credits, for a maximum of twenty (20) credits per activity.

PI CME: Stroke Prevention In Atrial Fibrillation

In the United States an estimated 2.3 million individuals are currently affected by Atrial fibrillation (AF). It has been projected that by the year 2050 more than 5.6 million to nearly 16 million Americans will be affected by AF. Of particular concern is the association between AF, stroke and thromboembolism. AF has been associated with 15% of all strokes and with 36% of strokes in patients older than 80 years of age. This data suggests that the early identification and intervention in patients with AF at risk for stroke is crucial for improving outcomes.

20 AMA PRA Category 1 CME Credits™

>>Click here for additional details or to begin.

PI CME: Improving Outcomes in the Hospitalized Patient with Hyponatremia

This activity is developed in collaboration with the Society of Hospital Medicine. It is designed to help practitioners evaluate their clinical processes within hyponatremia care. Practitioners will learn to implement guideline-approved processes of care for hyponatremia patients, with special emphasis on risk stratification and identification of patients with t risk for the condition.

20 AMA PRA Category 1 CME Credits™

>>Click here for additional details or to begin.

Resources & Links
Social Network

Welcome to the CME-University Online Programs selection page. A complete listing of currently available online programs is provided below. To view program details associated with each listing click on the listed title of interest. To access course materials click the appropriate format available button (View PDF) (View Webcast), provided with each course detail.

To earn CE/CME credits you must review a course in its entirety and have successfully completed the course online post-exam. Online exams provide an immediate grade report along with a Letter of Completion. All Letters of Completion become a permanent part of your CME-University.com User Record and may be accessed anytime in the future for viewing and printing.

To refine the listing by a specific topic of interest, click a topic from the listing provided at the left side of this Online Programs section.

Details & Material Review Links
*       Update On Antiplatelet Therapy in Acute Coronary Syndromes
* Update On Antiplatelet Therapy in Acute Coronary Syndromes
Effective Date: 2/1/2013
Expiration Date: 2/1/2014
Credits: 1
Tuition: Free
Faculty:
Faculty photo
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI

Chief of Cardiology, VA Boston Healthcare System
Director, Integrated Interventional Cardiovascular Program at Brigham and Women’s Hospital and VA Boston Healthcare System
Senior Investigator, TIMI Study Group
Professor of Medicine, Harvard Medical School

Deepak L. Bhatt MD, MPH, is Chief of Cardiology at VA Boston Healthcare System and Director of the Integrated Interventional Cardiovascular Program at Brigham and Women’s Hospital and VA Boston Healthcare System. He is also a Senior Investigator in the TIMI Study Group and Professor of Medicine at Harvard Medical School. He received his medical doctorate from Cornell University and completed a Masters in Public Health with a concentration in clinical effectiveness at the Harvard School of Public Health.

Dr. Bhatt’s research interests include preventive cardiology; the optimal management of patients with acute coronary syndromes; and advanced techniques in cardiac, cerebral, and peripheral interventional cardiology. He was the international PI for the CHARISMA and CRESCENDO trials and co-PI of the CHAMPION trials. He served as chair of COGENT and helped lead STAMPEDE. He serves as the co-chair of the REACH registry. He is the current Chair of the AHA-GWTG Science Subcommittee.

Dr. Bhatt has authored or co-authored more than 500 publications. He is the editor of Essential Concepts in Cardiovascular Intervention and Guide to Peripheral and Cerebrovascular Intervention, as well as co-editor of the Handbook of Acute Coronary Syndromes. He is also the Associate Editor of clinical trials for the American College of Cardiology’s CardioSource. Dr. Bhatt has been listed in Best Doctors in America from 2005 to 2012.

Format:   Webcast
Description:

Acute coronary syndrome (ACS) is a significant contributor to morbidity, mortality and adverse outcomes for patient’s worldwide. In the United States, ACS is responsible for more than 1.5 million hospitalizations and more than 6 million emergency department visits each year. It has been estimated that the total health care costs related to ACS exceed $300 million within the first year following initial patient presentation. The standard of care for the management of ACS is re-establishing coronary circulation through invasive management (i.e. percutaneous coronary intervention [PCI] or coronary artery bypass grafting [CABG]) or through medical management. Recently the ST-Elevation myocardial infarction (STEMI), unstable angina/non-ST-Elevation myocardial infarction (UA/NSTEMI), and PCI guidelines have been updated. These updates recommend treatment for preventing further thrombotic events. Antithrombotic agents are a vital part of these medical and interventional strategies. In addition, new data are emerging on the optimal combinations of antithrombotic treatments, their timing, and appropriate targeted subgroups. This program will review the new guidelines, recent data on the use of antithrombotic therapy, and strategies for improving outcomes in patients with ACS.

IMPORTANT PROGRAM VIEWING INFORMATION: To participate in this program you must be registered and logged in to this website.